
Professor Anneke Lucassen
Anneke was appointed Director of the CPM in August 2021. She is delighted to return to Oxford, and the Wellcome Centre for Human Genetics, after 2 decades as Professor at the Faculty of Medicine, University of Southampton. She also holds an honorary consultant physician post, now at the Oxford regional genetics service. Her research focuses on the ethical and legal aspects of developments in genetics and genomics.
Much more information on Anneke’s research can be found here.
Recent publications
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK).
Alice Garrett, Sophie Allen, Miranda Durkie, et al (2024), Genetics in medicine : official journal of the American College of Medical Genetics, 27
Why digital innovation may not reduce healthcare's environmental footprint.
Gabrielle Samuel, Geoffrey M Anderson, Federica Lucivero, et al (2024), BMJ (Clinical research ed.), 385
Challenges of using whole genome sequencing in population newborn screening.
Rachel Horton, Caroline F Wright, Helen V Firth, et al (2024), BMJ (Clinical research ed.), 384
Ancestry, race and ethnicity: the role and relevance of language in clinical genetics practice.
Melody Grace Redman, Rachel Helen Horton, Helena Carley, et al (2024), Journal of medical genetics, 61
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges
Padraig Dixon, Rachel Horton, William Newman, et al (2024), Health Economics, Policy and Law, 19